NO307176B1 - Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat - Google Patents

Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat

Info

Publication number
NO307176B1
NO307176B1 NO963775A NO963775A NO307176B1 NO 307176 B1 NO307176 B1 NO 307176B1 NO 963775 A NO963775 A NO 963775A NO 963775 A NO963775 A NO 963775A NO 307176 B1 NO307176 B1 NO 307176B1
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
receptor antagonists
indole derivatives
cck receptor
cck
Prior art date
Application number
NO963775A
Other languages
English (en)
Norwegian (no)
Other versions
NO963775D0 (no
NO963775L (no
Inventor
David Christopher Horwell
Janak Khimchand Padia
Martyn Clive Pritchard
Bharat Kalidas Trivedi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to NO963775A priority Critical patent/NO307176B1/no
Publication of NO963775D0 publication Critical patent/NO963775D0/no
Publication of NO963775L publication Critical patent/NO963775L/no
Publication of NO307176B1 publication Critical patent/NO307176B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO963775A 1994-03-10 1996-09-09 Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat NO307176B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO963775A NO307176B1 (no) 1994-03-10 1996-09-09 Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1994/002573 WO1995024389A1 (en) 1994-03-10 1994-03-10 Indole derivatives as cck receptor antagonists
NO963775A NO307176B1 (no) 1994-03-10 1996-09-09 Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat

Publications (3)

Publication Number Publication Date
NO963775D0 NO963775D0 (no) 1996-09-09
NO963775L NO963775L (no) 1996-09-09
NO307176B1 true NO307176B1 (no) 2000-02-21

Family

ID=22242333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963775A NO307176B1 (no) 1994-03-10 1996-09-09 Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat

Country Status (8)

Country Link
EP (1) EP0749422A1 (ja)
JP (1) JP3361100B2 (ja)
KR (1) KR100311329B1 (ja)
AU (1) AU677844B2 (ja)
FI (1) FI109689B (ja)
NO (1) NO307176B1 (ja)
NZ (1) NZ266052A (ja)
WO (1) WO1995024389A1 (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010089A (en) * 1988-08-12 1991-04-23 Biomeasure, Inc. CCK antagonists and their use in treating gastrointestinal disorders
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives

Also Published As

Publication number Publication date
NZ266052A (en) 1999-07-29
NO963775D0 (no) 1996-09-09
KR970701694A (ko) 1997-04-12
EP0749422A1 (en) 1996-12-27
JP3361100B2 (ja) 2003-01-07
JPH09510440A (ja) 1997-10-21
FI963463A (fi) 1996-09-04
KR100311329B1 (ko) 2002-02-28
AU6663394A (en) 1995-09-25
NO963775L (no) 1996-09-09
WO1995024389A1 (en) 1995-09-14
FI963463A0 (fi) 1996-09-04
FI109689B (fi) 2002-09-30
AU677844B2 (en) 1997-05-08

Similar Documents

Publication Publication Date Title
NZ301265A (en) Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof
DK1119557T3 (da) Indeno-, naphto- og benzocyclohepta-dihydrothiazolderivater, fremstilling deraf og anvendelse deraf som anorektiske medikamenter
NO307335B1 (no) Substituerte N-(indol-2-karbonyl)-<beta>-alaninamider, anvendelse derav og farmasøytisk preparat
DK1035115T3 (da) 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister
NO942316D0 (no) Isatinderivater, fremgangsmåter for deres fremstilling og farmasöytisk preparat omfattende slike derivater
DK0901470T3 (da) Indolderivater egnede som endothelinreceptorantagonister
NO306398B1 (no) Substituerte N-(indol-2-karbonyl) glycinamider, anvendelse derav, mellomprodukt og farmasöytisk preparat
NO20021719L (no) 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
NO20000108D0 (no) Sulfonamid-derivater som er 5-HT6-reseptorantagonister og fremgangsmåte for deres fremstilling
NO20013809L (no) Indolderivater og anvendelse derav som MCP-1 antagonister
NO20004215D0 (no) Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav
NO20006138D0 (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
NO996372L (no) Fast farmasøytisk preparat inneholdende benzofuanderivater
NO306257B1 (no) 11-(substituert fenyl)-östra-4,9-dien-derivater, farmasöytisk preparat og anvendelse derav
NO974043L (no) Indolderivater som EAA-antagonister
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DK0912556T3 (da) Indolinderivater, der er anvendelige som 5-HT-2C-receptorantagonister
DK1296961T3 (da) 1,4-diazepan-2,5-dionderivater og anvendelse deraf som NK-1-receptorantagonister
NO985972D0 (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
NO307176B1 (no) Indol-derivater som CCK-reseptorantagonister, anvendelse derav og farmasoeytisk preparat
NO20003284L (no) Farmasøytisk preparat for oral administrering
IS2024B (is) Indól og 2,3-díhýdróindól afleiður, framleiðsla þeirra og notkun
IT1296975B1 (it) Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees